Login / Signup

Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab-Authors' reply.

Anne S StrikG R D'Haens
Published in: Alimentary pharmacology & therapeutics (2019)
Keyphrases
  • ulcerative colitis
  • patients with inflammatory bowel disease